Skip to main content
Premium Trial:

Request an Annual Quote

Roche Acquires NGS Target-Enrichment Tech from AbVitro

NEW YORK (GenomeWeb) – Roche said today that it has acquired the exclusive rights to next-generation sequencing target enrichment technology from AbVitro, a company focused on therapeutic target discovery.

Under the terms of the agreement, the two companies will collaborate to develop the technology, called primer extension-based target enrichment (PETE). Roche plans to use PETE to support next-generation sequencing directly from blood or other biological samples. In addition, Roche will incorporate the PETE technology into the Roche Sequencing Unit R&D pipeline to support its clinical sequencing strategy.

"The potential of this technology will allow Roche to optimize our sequencing portfolio to provide a full workflow solution for our customers," Dan Zabrowski, head of Roche Tissue Diagnostics and the Sequencing Unit, said in a statement. "We look forward to advancing this technology in order to streamline sequencing methods for easy-to-use clinical applications."

Francois Vigneault, president, CSO and co-founder of AbVitro, added in a statement that the technology "surpasses current industry standards and we believe Roche to be incredibly well positioned to create a true disruption in the next-generation sample prep market."

AbVitro is developing single-cell immune sequencing technology based on work by co-founder George Church of Harvard Medical School. According to the company, the platform enables the identification of complete natively paired B-cell antibodies and T-cell receptors across millions of single cells and can then be used to identify novel therapeutic targets and antibodies to cancer and autoimmune diseases.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.